Arbutus Biopharma Corp (NASDAQ: ABUS) started the day on Thursday, with a price increase of 3.73% at $3.34, before settling in for the price of
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -5.07% drop from the session before settling in for the closing price of $3.35. A 52-week range
On Monday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -4.39% drop from the session before settling in for the closing price of $3.42. A 52-week range
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -0.31% drop from the session before settling in for the closing price of $3.19. A 52-week range
Arbutus Biopharma Corp (NASDAQ: ABUS) on Tuesday, plunged -2.54% from the previous trading day, before settling in for the closing price of $3.55. Within the
As on Wednesday, Arbutus Biopharma Corp (NASDAQ: ABUS) started slowly as it slid -3.19% to $3.64, before settling in for the price of $3.76 at
Arbutus Biopharma Corp (NASDAQ: ABUS) started the day on Wednesday, with a price increase of 9.68% at $3.74, before settling in for the price of
On Monday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -2.56% drop from the session before settling in for the closing price of $3.51. A 52-week range
A new trading day began on Monday, with Arbutus Biopharma Corp (NASDAQ: ABUS) stock price down -3.30% from the previous day of trading, before settling
Witnessing the stock’s movement on the chart, on Thursday, Arbutus Biopharma Corp (NASDAQ: ABUS) had a quiet start as it plunged -0.55% to $3.63, before
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
